CXCL9 and cancer: On the other hand the serum levels of ADIPOQ, CXCL9, PECAM-1, Prolactin, sVEGFR-1 and sVEGFR-2 in the T2D-HCC patients were higher than those of patients with only T2D while they were similar to those of HCC patients, confirming that these proteins are specific for the cancer presence.